ABVC BioPharma Postpones Distribution of BioKey Shares to Aug 21, 2026

What Happened ABVC BioPharma, Inc. filed an 8-K (Item 8.01) reporting that it postponed the previously scheduled distribution of BioKey (Cayman), Inc. ordinary shares from August 3, 2026 to August 21, 2026. The company said the postponement, determined on August 3, 2026, provides additional time to complete administrative, regulatory and tax-related matters. The 8-K was filed August 12, 2026.

Key Details

• Distribution now scheduled for August 21, 2026 (previously August 3, 2026).
• Record date remains July 24, 2026.
• Distribution ratio unchanged: 0.169464 BioKey ordinary shares for each ABVC common share held as of the record date.
• The previously announced ex-dividend date is being revised; ABVC will announce the new ex-dividend date after finalizing remaining matters. The company coordinated the revised mechanics with Nasdaq, DTC and its transfer agent.

Why It Matters For ABVC shareholders, the postponement delays receipt of BioKey shares and changes the timing for any trading or tax planning tied to the distribution. The unchanged record date and distribution ratio mean entitlements are not reduced, but investors who trade around the future ex-dividend date should watch for the company’s announcement of the revised ex-dividend date.